Genexine Market Cap

Genexine has a market cap or net worth of 226.03 billion as of August 14, 2025. Its market cap has decreased by -21.76% in one year.

Market Cap

226.03B

Enterprise Value

242.20B

Revenue

5.81B

Ranking

n/a

PE Ratio

n/a

Stock Price

4,970.00

Market Cap Chart

Since September 15, 2009, Genexine's market cap has increased from 109.02B to 226.03B, an increase of 107.33%. That is a compound annual growth rate of 4.69%.

Market Cap History

Date	Market Cap	% Change
Aug 13, 2025	224.44B	-7.58%
Dec 30, 2024	242.86B	-40.82%
Dec 28, 2023	410.35B	-12.73%
Dec 29, 2022	470.21B	-67.78%
Dec 30, 2021	1,459.20B	-52.47%
Dec 30, 2020	3,069.93B	106.72%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	72.67T
Celltrion	38.80T
ALTEOGEN	24.00T
Yuhan	8,487.38B
Peptron	8,130.78B
SK Biopharmaceuticals	7,846.99B
PharmaResearch	6,909.12B
LigaChem Biosciences	5,648.08B

Market Cap Rankings